Cue Health Inc (HLTH)

$0.1626

Market is closed - opens 7 PM, 15 Apr 2024

Insights on Cue Health Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 7.59M → 18.79M (in $), with an average increase of 35.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -46.97M → -148.43M (in $), with an average decrease of 216.0% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 39.9% return, outperforming this stock by 129.9%

Performance

  • $0.16
    $0.18
    $0.16
    downward going graph

    0.0%

    Downside

    Day's Volatility :9.45%

    Upside

    9.45%

    downward going graph
  • $0.16
    $1.77
    $0.16
    downward going graph

    0.0%

    Downside

    52 Weeks Volatility :90.96%

    Upside

    90.96%

    downward going graph

Returns

PeriodCue Health IncSector (Health Care)Index (Russel 2000)
3 Months
-22.28%
-1.1%
0.0%
6 Months
-60.82%
6.7%
0.0%
1 Year
-89.09%
3.2%
-0.7%
3 Years
-99.19%
15.2%
-21.6%

Highlights

Market Capitalization
27.3M
Book Value
$1.61
Earnings Per Share (EPS)
-2.44
Wall Street Target Price
0.75
Profit Margin
0.0%
Operating Margin TTM
-283.46%
Return On Assets TTM
-31.88%
Return On Equity TTM
-90.35%
Revenue TTM
70.9M
Revenue Per Share TTM
0.46
Quarterly Revenue Growth YOY
-87.2%
Gross Profit TTM
-17.9M
EBITDA
-219.2M
Diluted Eps TTM
-2.44
Quarterly Earnings Growth YOY
-0.77
EPS Estimate Current Year
-1.1
EPS Estimate Next Year
-0.65
EPS Estimate Current Quarter
-0.44
EPS Estimate Next Quarter
-0.26

Analyst Recommendation

Buy
    70%Buy
    30%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Cue Health Inc(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
3
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 361.25%

Current $0.16
Target $0.75

Company Financials

FY19Y/Y Change
Revenue
6.6M
-
Net Income
-21.1M
-
Net Profit Margin
-317.94%
-
FY20Y/Y Change
Revenue
23.0M
↑ 246.41%
Net Income
-48.4M
↑ 129.66%
Net Profit Margin
-210.79%
↑ 107.15%
FY21Y/Y Change
Revenue
618.1M
↑ 2592.92%
Net Income
86.4M
↓ 278.61%
Net Profit Margin
13.98%
↑ 224.77%
FY22Y/Y Change
Revenue
483.5M
↓ 21.78%
Net Income
-194.1M
↓ 324.56%
Net Profit Margin
-40.14%
↓ 54.12%
FY23Y/Y Change
Revenue
70.9M
↓ 85.33%
Net Income
-373.5M
↑ 92.45%
Net Profit Margin
-526.48%
↓ 486.34%
Q3 FY22Q/Q Change
Revenue
66.7M
↓ 20.97%
Net Income
-66.3M
↓ 33.06%
Net Profit Margin
-99.46%
↑ 17.97%
Q4 FY22Q/Q Change
Revenue
146.8M
↑ 120.19%
Net Income
-31.5M
↓ 52.48%
Net Profit Margin
-21.47%
↑ 77.99%
Q1 FY23Q/Q Change
Revenue
24.5M
↓ 83.31%
Net Income
-92.8M
↑ 194.44%
Net Profit Margin
-378.73%
↓ 357.26%
Q2 FY23Q/Q Change
Revenue
7.6M
↓ 69.01%
Net Income
-83.9M
↓ 9.6%
Net Profit Margin
-1.1K%
↓ 726.05%
Q3 FY23Q/Q Change
Revenue
14.8M
↑ 94.4%
Net Income
-47.0M
↓ 43.99%
Net Profit Margin
-318.29%
↑ 786.49%
Q4 FY23Q/Q Change
Revenue
18.8M
↑ 27.38%
Net Income
-148.4M
↑ 216.01%
Net Profit Margin
-789.62%
↓ 471.33%
FY19Y/Y Change
Total Assets
27.4M
-
Total Liabilities
85.5M
-
FY20Y/Y Change
Total Assets
316.3M
↑ 1056.13%
Total Liabilities
417.7M
↑ 388.57%
FY21Y/Y Change
Total Assets
940.1M
↑ 197.18%
Total Liabilities
233.3M
↓ 44.15%
FY22Y/Y Change
Total Assets
694.6M
↓ 26.11%
Total Liabilities
118.1M
↓ 49.39%
FY23Y/Y Change
Total Assets
339.8M
↓ 51.08%
Total Liabilities
89.5M
↓ 24.18%
Q3 FY22Q/Q Change
Total Assets
825.0M
↓ 9.74%
Total Liabilities
235.1M
↓ 14.11%
Q4 FY22Q/Q Change
Total Assets
694.6M
↓ 15.81%
Total Liabilities
118.1M
↓ 49.77%
Q1 FY23Q/Q Change
Total Assets
608.6M
↓ 12.38%
Total Liabilities
112.7M
↓ 4.56%
Q2 FY23Q/Q Change
Total Assets
523.9M
↓ 13.92%
Total Liabilities
100.7M
↓ 10.66%
Q3 FY23Q/Q Change
Total Assets
492.3M
↓ 6.03%
Total Liabilities
103.5M
↑ 2.76%
Q4 FY23Q/Q Change
Total Assets
339.8M
↓ 30.98%
Total Liabilities
89.5M
↓ 13.46%
FY19Y/Y Change
Operating Cash Flow
-13.0M
-
Investing Cash Flow
-2.9M
-
Financing Cash Flow
3.6M
-
FY20Y/Y Change
Operating Cash Flow
92.7M
↓ 812.95%
Investing Cash Flow
-78.1M
↑ 2553.58%
Financing Cash Flow
100.2M
↑ 2676.81%
FY21Y/Y Change
Operating Cash Flow
-9.4M
↓ 110.2%
Investing Cash Flow
-115.7M
↑ 48.07%
Financing Cash Flow
419.6M
↑ 318.6%
FY22Y/Y Change
Operating Cash Flow
-111.9M
↑ 1084.45%
Investing Cash Flow
-63.0M
↓ 45.53%
Financing Cash Flow
-6.4M
↓ 101.53%
Q3 FY22Q/Q Change
Operating Cash Flow
-39.9M
↓ 23.01%
Investing Cash Flow
-18.3M
↓ 11.44%
Financing Cash Flow
-296.0K
↓ 91.26%
Q4 FY22Q/Q Change
Operating Cash Flow
-51.7M
↑ 29.55%
Investing Cash Flow
-10.1M
↓ 44.79%
Financing Cash Flow
-1.9M
↑ 532.77%
Q1 FY23Q/Q Change
Operating Cash Flow
-53.9M
↑ 4.22%
Investing Cash Flow
-8.3M
↓ 17.52%
Financing Cash Flow
-1.1M
↓ 39.78%
Q2 FY23Q/Q Change
Operating Cash Flow
-42.7M
↓ 20.82%
Investing Cash Flow
-6.0M
↓ 27.99%
Financing Cash Flow
-996.0K
↓ 11.7%

Technicals Summary

Sell

Neutral

Buy

Cue Health Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cue Health Inc
Cue Health Inc
-17.13%
-60.82%
-89.09%
-99.19%
-99.19%
Solventum Corp
Solventum Corp
-9.19%
-9.19%
-9.19%
-9.19%
-9.19%
Veeva Systems Inc.
Veeva Systems Inc.
-8.92%
-2.46%
15.48%
-25.05%
55.88%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-3.5%
29.01%
4.3%
42.64%
42.64%
Healthequity Inc
Healthequity Inc
-1.95%
6.5%
35.87%
14.06%
6.34%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cue Health Inc
Cue Health Inc
10.43
NA
NA
-1.1
-0.9
-0.32
NA
1.61
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
65.5
65.5
1.38
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
29.07
29.07
19.9
4.29
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
124.7
124.7
2.33
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cue Health Inc
Cue Health Inc
Buy
$27.3M
-99.19%
10.43
0.0%
Solventum Corp
Solventum Corp
NA
$11.7B
-9.19%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$34.0B
55.88%
65.5
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$40.3B
42.64%
29.07
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
6.34%
124.7
5.57%

Institutional Holdings

  • Tarsadia Capital, LLC

    6.74%
  • Oakmont Corp

    6.05%
  • Decheng Capital LLC

    5.67%
  • Goldman Sachs Group Inc

    4.95%
  • Madrone Advisors LLC

    4.47%
  • Jabodon PT Co

    2.51%

Company Information

cue, a revolutionary device for tracking health information at the molecular level. for the first time, consumers can track 5 key health and lifestyle indicators: inflammation, vitamin d, fertility, influenza, and testosterone in just minutes, at home. cue sends the data via bluetooth 4.0 to the user's smartphone, where the free cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level. by simply adding a noninvasive droplet of saliva, blood, or nasal swab, you can access deep information about your body only previously available from a lab -- on demand and on your schedule. interactive charts put you in touch with your health, making it easy to discover new trends, monitor your progress, and share it with the people who matter most. cue also features life feed, an incredible new smartphone-based way to visualize the daily effect of activity, food, and sleep on your molecular health. cue makes research-based recommendations for foods proven to sup

Organization
Cue Health Inc
Employees
726
CEO
Mr. Christopher K. Achar
Industry
Health Services

FAQs